Legend Biotech (LEGN)

• Market cap: $5.59B
• 1 day: -2.32%
• 5 days: -5.25%
• 1 month: -8.85%
• 3 months: -19.68%
• 6 months: 8.96%
• Year to date: -12.78%
• 1 year: -24.07%
• 5 years: 9.67%
• 10 years: -18.14%
• Sector: Healthcare
• Industry: Biotechnology

About: Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Employees: 2,900